Author:
Guimerà Jordi,Martínez Ana,Bauza Jose Luis,Sanchís Pilar,Pieras Enrique,Grases Felix
Abstract
AbstractThe objective is to evaluate the effect of phytate supplements on calciuria in patients with urinary stones and elevated bone resorption. The secondary objective is to analyze the therapeutic effect of phytate based on measurements of serum markers of bone resorption. This is a controlled randomized study included patients according to predefined inclusion and exclusion criteria, and randomized them into two groups. Patients in the phytate group received a 380 mg capsule of calcium-magnesium InsP6 (Salvat Laboratories®) every 24 h for 3 months and patients in the control group received no treatment. All included patients were male or female, 18–65 years old, had hypercalciuria (> 250 mg/24 h), had a ß-Crosslaps level greater than 0.4 ng/mL, and had bone densitometry results indicative of osteopenia or osteoporosis in the femur and/or spine. At study onset, calciuria was 321 ± 52 mg/24 h in the phytate group and 305 ± 57 mg/24 h in the control group (p > 0.05). At 3 months, calciuria was significantly lower in the phytate group than the control group (226 ± 45 mg/24 h vs. 304 ± 58 mg/24 h, p < 0.05). At study onset, the mean ß-CrossLaps level was 1.25 ± 0.72 ng/mL in the phytate group and 0.57 ± 0.13 ng/mL in the control group (p < 0.05). However, at 3 months, the ß-CrossLaps level was significantly lower in the phytate group than in the control group (0.57 ± 0.13 ng/mL vs. 0.77 ± 0.42 ng/mL, p < 0.05). Phytate reduced calciuria in patients with hypercalciuria secondary to bone resorption. The ß-CrossLaps assay was effective for evaluating the efficacy of phytate on hypercalciuria during follow-up.
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Grases F, Conte A, March JG, Genestar C, Costa-Bauzá A, Martin M et al (1994) Epidemiology of urinary stone disease in the Balearic Islands community. Int Urol Nephrol 26(2):145–150
2. Levy FL, Adams-Huet B, Pak CYC (1995) Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med 98(1):50–59
3. Bijelic R, Milicevic S, Balaban J (2016) Correlation of osteoporosis and calcium urolithiasis in adult population. Med Arch (Sarajevo, Bosnia Herzegovina) 70(1):66–68
4. Lu YM, Li CC, Juan YS, Lee YC, Chien TM (2020) Urolithiasis increases the risk of subsequent onset of osteoporosis. J Bone Miner Metab [Internet]. 38(1):38–43. https://doi.org/10.1007/s00774-019-01022-y
5. Ryan LE, Ing SW (2018) Idiopathic hypercalciuria: can we prevent stones and protect bones? Cleve Clin J Med 85(1):47–54
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献